Vinva Investment Management Ltd Acquires Shares of 3,113 STERIS plc (NYSE:STE)

Vinva Investment Management Ltd acquired a new stake in shares of STERIS plc (NYSE:STE - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,113 shares of the medical equipment provider's stock, valued at approximately $638,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Avalon Trust Co bought a new position in shares of STERIS in the fourth quarter valued at approximately $30,000. Human Investing LLC purchased a new stake in STERIS in the 4th quarter worth approximately $31,000. Anfield Capital Management LLC boosted its holdings in STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock valued at $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division grew its position in shares of STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC increased its holdings in shares of STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock worth $44,000 after purchasing an additional 137 shares during the period. Institutional investors own 94.69% of the company's stock.

STERIS Trading Up 0.6 %

STERIS stock traded up $1.25 during mid-day trading on Wednesday, hitting $223.03. The company's stock had a trading volume of 578,151 shares, compared to its average volume of 536,292. The business has a 50 day moving average price of $221.62 and a 200-day moving average price of $221.60. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The stock has a market cap of $21.91 billion, a price-to-earnings ratio of 47.35 and a beta of 0.92.

Remove Ads

STERIS (NYSE:STE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. As a group, analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.02%. The ex-dividend date was Thursday, February 20th. STERIS's dividend payout ratio (DPR) is currently 48.41%.

Wall Street Analyst Weigh In

STE has been the subject of several research analyst reports. JMP Securities reissued a "market outperform" rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a research report on Monday, February 3rd. Finally, Stephens restated an "overweight" rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, STERIS has a consensus rating of "Moderate Buy" and a consensus price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.